Mutations in RBM10 were described in lung and pancreatic adenocarcinomas and shown to be associated with male sex and an improved prognosis, respectively (Cancer Genome Atlas Research Network, 2014, Witkiewicz et al., 2015). Here, RBM10 is linked to pancreatic adenocarcinoma.